Cargando...
Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease
AIMS: Patients with adult congenital heart disease (ACHD) carry an increased risk for sudden cardiac death. Implantable cardioverter‐defibrillator (ICD) therapy may be challenging in these patients due to anatomical barriers, repeated cardiac surgery, or complicated transvenous access. Thus, the sub...
Gardado en:
| Publicado en: | ESC Heart Fail |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8006645/ https://ncbi.nlm.nih.gov/pubmed/33538124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13243 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|